Unknown

Dataset Information

0

Hippocampal GAD67 Transduction Using rAAV8 Regulates Epileptogenesis in EL Mice.


ABSTRACT: Gene therapy has been employed as a therapeutic approach for intractable focal epilepsies. Considering the potential of focal GABAergic neuromodulation in regulating epileptogenesis, the GABA-producing enzyme, ?-aminobutyric acid decarboxylase 67 (GAD67), is highly suitable for epilepsy therapy. The EL/Suz (EL) mouse is a model of multifactorial temporal lobe epilepsy. In the present study, we examined focal gene transduction in epileptic EL mice using recombinant adeno-associated virus serotype 8 (rAAV8) expressing human GAD67 to enhance GABA-mediated neural inhibition. Eight-week-old mice were bilaterally injected with rAAV8-GFP or rAAV8-GAD67 in the hippocampal CA3 region. After four weeks, the GAD67-transduced EL mice, but not the rAAV-GFP-treated EL mice, exhibited a significant reduction in seizure generation. The GAD67-mediated depression became stable after 14 weeks. The excitability of the CA3 region was markedly reduced in the GAD67-transduced EL mice, consistent with the results of the Ca2+ imaging using hippocampal slices. In addition, downregulation of c-Fos expression was observed in GAD67-transduced hippocampi. Our findings showed that rAAV8-GAD67 induced significant changes in the GABAergic system in the EL hippocampus. Thus, rAAV8-mediated GAD67 gene transfer is a promising therapeutic strategy for the treatment of epilepsies.

SUBMITTER: Shimazaki K 

PROVIDER: S-EPMC6369250 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hippocampal GAD67 Transduction Using rAAV8 Regulates Epileptogenesis in EL Mice.

Shimazaki Kuniko K   Kobari Takashi T   Oguro Keiji K   Yokota Hidenori H   Kasahara Yuko Y   Murashima Yoshiya Y   Watanabe Eiju E   Kawai Kensuke K   Okada Takashi T  

Molecular therapy. Methods & clinical development 20190108


Gene therapy has been employed as a therapeutic approach for intractable focal epilepsies. Considering the potential of focal GABAergic neuromodulation in regulating epileptogenesis, the GABA-producing enzyme, γ-aminobutyric acid decarboxylase 67 (GAD67), is highly suitable for epilepsy therapy. The EL/Suz (EL) mouse is a model of multifactorial temporal lobe epilepsy. In the present study, we examined focal gene transduction in epileptic EL mice using recombinant adeno-associated virus serotype  ...[more]

Similar Datasets

| S-EPMC3775928 | biostudies-literature
| S-EPMC6856617 | biostudies-literature
| S-EPMC8022328 | biostudies-literature
| S-EPMC7298335 | biostudies-literature
| S-EPMC4503715 | biostudies-literature
| S-EPMC3741044 | biostudies-literature
| S-EPMC5925580 | biostudies-literature
| S-EPMC5774867 | biostudies-literature
| S-EPMC4281237 | biostudies-literature
| S-EPMC5368595 | biostudies-literature